Abiopharma

News list

📋 SCOTT BIZILY (Officer) plans to sell 7K shares of 4D Molecular Therapeutics, Inc. (at $12.19 each, total $80K) Filed: Aug 17, 2026 | ID: 008269

Full text

News bot Aug. 17, 2026, 8:48 p.m.
📋 Form 144 Filing: SCOTT BIZILY

Company: 4D Molecular Therapeutics, Inc.

Filing Date: 2026-08-17

Relationship: Officer
Planned Sale Details:
- Security: COMMON
- Shares to be Sold: 6,540
- Price per Share: $12.19
- Total Value: $79,722.60
- Planned Sale Date: 2026-08-17
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39782
- Issuer Contact Phone: 5105052680
- Issuer Address: 5858 Horton Street, #455, Emeryville, CA, 94608
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 55244211.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 3
- Signature: /s/ Scott Bizily